Showing results (71-80 of 2,529) with videos related to
Sort By:
Pageof 253
International Journal of Clinical Pharmacy|February 8, 2021
Utilization of neurosurgical perioperative antimicrobial prophylaxis in a Chinese teaching hospitalWeiwei Zhang, Huijie Meng, Chientai Mao, et al.International Journal of Clinical Pharmacy|February 17, 2017
Appropriateness of surgical antibiotic prophylaxis for breast surgery proceduresSmeem Jaber, Crystal Rogers, Bruce Sunderland, et al.International Journal of Clinical Pharmacy|March 11, 2017
Difficulties in swallowing oral medications in JordanLinda Tahaineh, Mayyada WazaifyInternational Journal of Clinical Pharmacy|March 11, 2017
Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case-control studyAlenka Premuš Marušič, Daniel Petrovič, Aleš Mrhar, et al.International Journal of Clinical Pharmacy|March 11, 2017
Patient preferences regarding atrial fibrillation stroke prophylaxis in patients at potential risk of atrial fibrillationNicholas T Edwards, Erica D Greanya, I Fan Kuo, et al.International Journal of Clinical Pharmacy|March 11, 2017
Development of a risk score for QTc-prolongation: the RISQ-PATH studyEline Vandael, Bert Vandenberk, Joris Vandenberghe, et al.International Journal of Clinical Pharmacy|September 8, 2019
Evaluation of the clinical pharmacist role in improving clinical outcomes in patients with lower urinary tract symptoms due to benign prostatic hyperplasiaMera Ababneh, Duaa Shamieh, Saddam Al Demour, et al.International Journal of Clinical Pharmacy|July 13, 2019
Pharmacist-led pre-treatment assessment, management and outcomes in a Hepatitis C treatment patient cohortMiriam Coghlan, Aisling O'Leary, Gail Melanophy, et al.International Journal of Clinical Pharmacy|April 10, 2025
Evaluating a customised large language model (DELSTAR) and its ability to address medication-related questions associated with delirium: a quantitative exploratory studyKatharina Teresa Spagl, Edward William Watson, Adam Jatowt, et al.International Journal of Clinical Pharmacy|April 9, 2025
Real-world safety of deucravacitinib: insights from the Food and Drug Administration Adverse Event Reporting SystemKaidi Zhao, Shengxiang Xiao, Yang Zhao, et al.Pageof 253